Stock Taper
VIVS
VIVOSIM LABS, INC.
NASDAQ
$0.29
▲ UP 3.06% (0.01)

KEY STATISTICS

Market Cap$734.63 K
52w High$5.30
52w Low$0.26
Dividend Yield
Frequency
P/E-0.06
Volume715.76K
Shares Out.2.57M

COMPANY

LEADERSHIP

Keith E. Murphy
CHIEF EXECUTIVE
Keith E. Murphy

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 14, 2012
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
15

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.
NOV
5
THU

PRICE

$0.29 ▲ UP 3.06% (+$0.01)
$0.28$0.28$0.29$0.299:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM0.29

About VivoSim Labs, Inc.

https://vivosim.ai ↗

VivoSim Labs, Inc. develops 3D human tissues using proprietary bioprinters for disease modeling and drug testing, with lead candidates in clinical trials for inflammatory bowel disease and liver fibrosis.

INDUSTRY

Biotechnology

A SERVICE VIVOSIM LABS, INC. IS KNOWN FOR

NAMkind™ Platform

NAMkind™ is a preclinical platform using 3D human liver and intestine models to assess drug toxicity, offering a human-relevant alternative to animal testing for early prediction of drug-induced injuries.

COMPETITORS

COMPETITOR

Revenue by Products

IconPRODUCTQ1-2027
Royalty$18K

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

DIRECTOR
Cohen Douglas Jay
Purchase · 15.0K shares
2026-01-27
DIRECTOR, OFFICER: EXECUTIVE CHAIRMAN
Murphy Keith
Purchase · 15.0K shares
2026-01-27
DIRECTOR
Milhous Alison Tjosvold
Purchase · 15.0K shares
2026-01-27
DIRECTOR
Gobel David
Purchase · 15.0K shares
2026-01-27

SECTORS PEERS

PEERPRICE
XTLB$2.78COMPARE
CYCN$3.89COMPARE
KTTA$0.54COMPARE
PLRZ$10.30COMPARE
QNRX$5.57COMPARE
PMCB$0.53COMPARE
TCRT$1.76COMPARE
RADX$2.44COMPARE